juglone and shikonin
juglone has been researched along with shikonin in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Assimopoulou, AN; Couladouros, EA; Li, T; Mellidis, AS; Papageorgiou, VP; Pitsinos, EN; Plyta, ZF | 1 |
| Fischer, TC; Gosch, C; Gselmann, M; Mirbeth, B; Stich, K; Thallmair, V | 1 |
| Cui, J; Jia, J | 1 |
| Bao, JL; Chen, XP; Huang, MQ; Lu, JJ; Wang, YT; Wu, GS; Xu, WS | 1 |
Reviews
1 review(s) available for juglone and shikonin
| Article | Year |
|---|---|
Quinones derived from plant secondary metabolites as anti-cancer agents.
Topics: Anthraquinones; Antineoplastic Agents, Phytogenic; Benzoquinones; Cell Line, Tumor; Cell Survival; Humans; Naphthoquinones; Neoplasms; Plant Extracts | 2013 |
Other Studies
3 other study(ies) available for juglone and shikonin
| Article | Year |
|---|---|
Inhibition of topoisomerase I by naphthoquinone derivatives.
Topics: Enzyme Inhibitors; Naphthoquinones; Structure-Activity Relationship; Topoisomerase I Inhibitors; Zinc | 1998 |
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
Topics: Agrochemicals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Stability; Erwinia amylovora; Flowers; Germination; Hydrogen-Ion Concentration; Malus; Microbial Sensitivity Tests; Naphthoquinones; Plant Diseases; Quinones; Toxicity Tests | 2012 |
Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
Topics: Animals; Binding Sites; Catalytic Domain; Cell Survival; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Evaluation, Preclinical; Humans; Hydrogen Bonding; Molecular Docking Simulation; Naphthoquinones; Protease Inhibitors; SARS-CoV-2; Structure-Activity Relationship; Vero Cells; Viral Matrix Proteins | 2021 |